Back to Authors

Gajjar, Rohan A

Mayo Clinic

Department of Cardiovascular Medicine, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA.

Citations 1

Prognostic value of aortic valve calcification in non-severe aortic stenosis with preserved ejection fraction
Ye, Zi , Gajjar, Rohan , Foley, Thomas A. , Clavel, Marie‐Annick , Miranda, William R. , Padang, Ratnasari , Michelena, Héctor I. , Gajjar, Rohan A, Foley, Thomas , Clavel, Marie-Annick , Luis, S Allen, Padang, Ratnasari , Michelena, Hector I , Enriquez-Sarano, Maurice , Scott, Christopher G. , Nkomo, Vuyisile T. , Luis, Sushil Allen , Pislaru, Sorin V. , Enriquez‐Sarano, Maurice

European Heart Journal - Cardiovascular Imaging | June 3, 2024 | Volume: 25 | Issue: 10 | Pages: 1432-1440

10.1093/ehjci/jeae145 Get It

Abstract Aims Aortic valve calcification (AVC) is prognostic in patients with aortic stenosis (AS). We assessed the AVC prognostic value in non-severe AS patients. Methods and results We conducted a retrospective study of 395 patients with non-severe AS, LVEF ≥ 50%. The Agatston method was used for CT AVC assessment. The log-rank test determined the best AVC cut-offs for survival under medical surveillance: 1185 arbitrary unit (AU) in men and 850 AU in women, lower than the established cut-offs for severe AS (2064 AU in men and 1274 AU in women). Patients were divided into 3 AVC groups based on these cut-offs: low (<1185 AU in men and <850 AU in women), sub-severe (1185–2064 AU in men and 850–1274 AU in women), and severe (>2064 AU in men and >1274 AU in women). Of 395 patients (mean age 73 ± 12 years, 60.5% men, aortic valve area 1.23 ± 0.30 cm2, mean pressure gradient 28 ± 8 mmHg), 218 underwent aortic valve intervention (AVI) and 158 deaths occurred during follow-up, 82 before AVI. Median survival time under medical surveillance was 2.1 (0.7–4.9) years. Compared with the low AVC group, both sub-severe and severe AVC groups had higher risk for all-cause death under medical surveillance after comprehensive adjustment including echocardiographic AS severity and coronary artery calcium score (all P ≤ 0.006); while mortality risk was similar between sub-severe and severe AVC groups (all P ≥ 0.2). This mortality risk pattern persisted in the overall survival analysis after adjustment for AVI. AVI was protective of all-cause death in the sub-severe and severe AVC (all P ≤ 0.01), but not in the low AVC groups. Conclusion Sub-severe AVC is a robust risk stratification parameter in patients with non-severe AS and may inform AVI timing.